High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents

Descripción del Articulo

Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) wer...

Descripción completa

id INEN_71c9f848b9dfdef51886926fdda53374
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/432
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
dc.title.none.fl_str_mv High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
title High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
spellingShingle High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
Kaliki, S
chemotherapy
enucleation
eye
high-risk features
histopathology
retinoblastoma
tumor
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
title_full High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
title_fullStr High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
title_full_unstemmed High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
title_sort High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continents
author Kaliki, S
author_facet Kaliki, S
Vempuluru, VS
Bakal, KR
Dorji, S
Tanna, V
Shields, CN
Fallon, SJ
Raval, V
Ahmad, A
Mushtaq, A
Hussain, M
Yousef, YA
Mohammad, M
Roy, SR
Huque, F
Tatiana, U
Yuri, S
Vladimir, P
Zambrano, SC
Alarcón-León, S
Valdiviezo-Zapata, C
Vargas-Martorellet, M
Gutierrez-Chira, C
Buitrago, M
Ortiz, JS
Diaz-Coronado, R
Tripathy, D
Rath, S
Patil, G
Berry, JL
Pike, S
Brown, B
Tanabe, M
Frenkel, S
Eiger-Moscovich, M
Pe'er, J
Shields, CL
Eagle, RC,, Jr
Laiton, A
Velasco, AM
Vega, K
Desimone, J
Bejjanki, KM
Kapoor, AG
Venkataraman, A
Bryant, V
Reddy, MA
Sagoo, MS
Hubbard, GB
Azarcon, CP
Olson, TA
Grossniklaus, H
Rolfe, O
Staffieri, SE
O'day, R
Mathew, AA
Elder, JE
Mckenzie, JD
Fabian, ID
Shemesh, R
Vishnevskia-Dai, V
Ali, MH
Jakati, S
Mishra, DK
Palkonda, VAR
author_role author
author2 Vempuluru, VS
Bakal, KR
Dorji, S
Tanna, V
Shields, CN
Fallon, SJ
Raval, V
Ahmad, A
Mushtaq, A
Hussain, M
Yousef, YA
Mohammad, M
Roy, SR
Huque, F
Tatiana, U
Yuri, S
Vladimir, P
Zambrano, SC
Alarcón-León, S
Valdiviezo-Zapata, C
Vargas-Martorellet, M
Gutierrez-Chira, C
Buitrago, M
Ortiz, JS
Diaz-Coronado, R
Tripathy, D
Rath, S
Patil, G
Berry, JL
Pike, S
Brown, B
Tanabe, M
Frenkel, S
Eiger-Moscovich, M
Pe'er, J
Shields, CL
Eagle, RC,, Jr
Laiton, A
Velasco, AM
Vega, K
Desimone, J
Bejjanki, KM
Kapoor, AG
Venkataraman, A
Bryant, V
Reddy, MA
Sagoo, MS
Hubbard, GB
Azarcon, CP
Olson, TA
Grossniklaus, H
Rolfe, O
Staffieri, SE
O'day, R
Mathew, AA
Elder, JE
Mckenzie, JD
Fabian, ID
Shemesh, R
Vishnevskia-Dai, V
Ali, MH
Jakati, S
Mishra, DK
Palkonda, VAR
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Kaliki, S
Vempuluru, VS
Bakal, KR
Dorji, S
Tanna, V
Shields, CN
Fallon, SJ
Raval, V
Ahmad, A
Mushtaq, A
Hussain, M
Yousef, YA
Mohammad, M
Roy, SR
Huque, F
Tatiana, U
Yuri, S
Vladimir, P
Zambrano, SC
Alarcón-León, S
Valdiviezo-Zapata, C
Vargas-Martorellet, M
Gutierrez-Chira, C
Buitrago, M
Ortiz, JS
Diaz-Coronado, R
Tripathy, D
Rath, S
Patil, G
Berry, JL
Pike, S
Brown, B
Tanabe, M
Frenkel, S
Eiger-Moscovich, M
Pe'er, J
Shields, CL
Eagle, RC,, Jr
Laiton, A
Velasco, AM
Vega, K
Desimone, J
Bejjanki, KM
Kapoor, AG
Venkataraman, A
Bryant, V
Reddy, MA
Sagoo, MS
Hubbard, GB
Azarcon, CP
Olson, TA
Grossniklaus, H
Rolfe, O
Staffieri, SE
O'day, R
Mathew, AA
Elder, JE
Mckenzie, JD
Fabian, ID
Shemesh, R
Vishnevskia-Dai, V
Ali, MH
Jakati, S
Mishra, DK
Palkonda, VAR
dc.subject.none.fl_str_mv chemotherapy
enucleation
eye
high-risk features
histopathology
retinoblastoma
tumor
topic chemotherapy
enucleation
eye
high-risk features
histopathology
retinoblastoma
tumor
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan-Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
publishDate 2024
dc.date.accessioned.none.fl_str_mv 2025-02-05T17:30:14Z
dc.date.available.none.fl_str_mv 2025-02-05T17:30:14Z
dc.date.issued.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.1097/IAE.0000000000004250
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/432
dc.identifier.journal.none.fl_str_mv Retina
identifier_str_mv 10.1097/IAE.0000000000004250
Retina
url https://hdl.handle.net/20.500.14703/432
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Lippincott Williams and Wilkins
dc.publisher.country.none.fl_str_mv US
publisher.none.fl_str_mv Lippincott Williams and Wilkins
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/backend/api/core/bitstreams/d926f075-b433-4a05-8d5a-db5417698a91/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/67ebd0d5-8e4b-4736-9906-db46a3b868cf/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/757cfa74-d4db-4e4d-9e64-a779e2ab2afe/download
bitstream.checksum.fl_str_mv 30cb438bc6678aca3a14ce335a9093ec
fc91026246c6589b5b085515c6ab664f
02d48dfdefae557def8a717bca5c9c6d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1868438555594850304
spelling PublicationKaliki, SVempuluru, VSBakal, KRDorji, STanna, VShields, CNFallon, SJRaval, VAhmad, AMushtaq, AHussain, MYousef, YAMohammad, MRoy, SRHuque, FTatiana, UYuri, SVladimir, PZambrano, SCAlarcón-León, SValdiviezo-Zapata, CVargas-Martorellet, MGutierrez-Chira, CBuitrago, MOrtiz, JSDiaz-Coronado, RTripathy, DRath, SPatil, GBerry, JLPike, SBrown, BTanabe, MFrenkel, SEiger-Moscovich, MPe'er, JShields, CLEagle, RC,, JrLaiton, AVelasco, AMVega, KDesimone, JBejjanki, KMKapoor, AGVenkataraman, ABryant, VReddy, MASagoo, MSHubbard, GBAzarcon, CPOlson, TAGrossniklaus, HRolfe, OStaffieri, SEO'day, RMathew, AAElder, JEMckenzie, JDFabian, IDShemesh, RVishnevskia-Dai, VAli, MHJakati, SMishra, DKPalkonda, VAR2025-02-05T17:30:14Z2025-02-05T17:30:14Z202410.1097/IAE.0000000000004250https://hdl.handle.net/20.500.14703/432RetinaPurpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes from five continents. Results: Of all, 923 (65%) were from Asia (AS), 27 (2%) from Australia (AUS), 120 (8%) from Europe (EUR), 162 (11%) from North America (NA), and 194 (14%) from South America (SA). Based on the continent (AS vs. AUS vs. EUR vs. NA vs. SA), the histopathological features included massive choroidal invasion (31% vs. 7% vs. 13% vs. 19% vs. 27%, P = 0.001), postlaminar optic nerve invasion (27% vs. 0% vs. 16% vs. 21% vs. 19%, P = 0.0006), scleral infiltration (5% vs. 0% vs. 4% vs. 2% vs. 7%, P = 0.13), and microscopic extrascleral infiltration (4% vs. 0% vs. <1% vs. <1% vs. 4%, P = 0.68). Adjuvant chemotherapy with/without orbital radiotherapy was given to 761 (53%) patients. Based on Kaplan-Meier estimates in different continents (AS vs. AUS vs. EUR vs. NA vs. SA), the 6-year risk of orbital tumor recurrence was 5% versus 2% versus 0% versus 0% versus 12% (P < 0.001), systemic metastasis was reported in 8% versus 5% versus 2% versus 0% versus 13% (P = 0.001), and death in 10% versus 3% versus 2% versus 0% versus 11% (P < 0.001) patients. Conclusion: There is a wide variation in the infiltrative histopathological features of retinoblastoma across continents, resulting in variable outcomes. SA and AS had a higher risk of orbital tumor recurrence, systemic metastasis, and death compared to AUS, EUR, and NA. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.application/pdfengLippincott Williams and WilkinsUSinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/chemotherapyenucleationeyehigh-risk featureshistopathologyretinoblastomatumorhttps://purl.org/pe-repo/ocde/ford#3.02.21High-risk histopathological features of retinoblastoma following primary enucleation: A Global Study Of 1,426 Patients From 5 Continentsinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALretina-44-2105.pdfapplication/pdf233118https://repositorio.inen.sld.pe/backend/api/core/bitstreams/d926f075-b433-4a05-8d5a-db5417698a91/download30cb438bc6678aca3a14ce335a9093ecMD51trueAnonymousREADTEXTretina-44-2105.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-05-09T08:00:45Z (GMT).Extracted texttext/plain52928https://repositorio.inen.sld.pe/backend/api/core/bitstreams/67ebd0d5-8e4b-4736-9906-db46a3b868cf/downloadfc91026246c6589b5b085515c6ab664fMD52falseAnonymousREADTHUMBNAILretina-44-2105.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-05-09T08:00:46Z (GMT).Generated Thumbnailimage/jpeg45834https://repositorio.inen.sld.pe/backend/api/core/bitstreams/757cfa74-d4db-4e4d-9e64-a779e2ab2afe/download02d48dfdefae557def8a717bca5c9c6dMD53falseAnonymousREAD20.500.14703/432oai:repositorio.inen.sld.pe:20.500.14703/4322026-02-15T16:53:39.304Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
score 12.821158
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).